Understanding how neurofilaments behave in amyotrophic lateral sclerosis
Official title: Identifying mechanisms of neurofilament regulation and turnover in amyotrophic lateral sclerosis
Funded at Washington University · NIH-10945644 · Data updated 2026-11-12
This study is looking at how certain proteins called neurofilaments behave in people with ALS, with the hope of finding new ways to track the disease and see how well treatments are working.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $558,182 |
| NIH project number | 1R01NS138499-01 |
| Project ID | NIH-10945644 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis.
✕Less likely to help
Patients with other neurodegenerative diseases or those without a diagnosis of ALS may not benefit from this research.
What this research studies
This research investigates the role of neurofilaments in amyotrophic lateral sclerosis (ALS), a severe neurodegenerative disease that leads to muscle weakness and respiratory failure. The team aims to identify how neurofilaments are regulated and how they change over time in ALS patients. By developing advanced assays to measure neurofilament levels and their modifications, the research seeks to improve the understanding of ALS progression and treatment response. This could help in identifying biomarkers that predict disease outcomes and treatment efficacy.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatment strategies for patients with ALS.
How similar studies have gone: Previous research has shown promise in using neurofilament levels as biomarkers in neurodegenerative diseases, indicating that this approach has potential for success.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Ly, Cindy V — Washington University
- Study coordinator: Ly, Cindy V
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
NUZ-001: a treatment option for ALS to protect nerve cells
A small molecule called NUZ-001 is being tested to help people with ALS by improving cell systems that keep proteins balanced and prevent harmful protein clumps.
-
Alpha5 integrin's role in ALS: how a cell switch worsens disease
Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.
-
C9orf72 ALS/FTD Prevent: prepping for future treatment
This grant aims to get ready for a preventive treatment for people who carry the C9orf72 genetic change that can lead to ALS or frontotemporal dementia.
-
Air pollutants and ALS: mapping environmental links to motor neuron disease
This NIH grant explores whether different air pollutants are linked to the development of ALS and uses a large U.S. data set to look for environmental risk factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.